FINANCIALS

URGN Urogen Pharma Ltd 1668243

Income Statement
Revenue	urgn20241231_10k	25,204,000
Net Income	urgn20241231_10k	-23,673,000
Profit Margin		-93.93%

Balance Sheet
Current Assets	295,097,000
Assets	301,943,000
Current Liabilities	32,787,000
Liabilities	276,428,000
Equity	25,515,000
Shares Out	48,682,000

Cash Flow Statement
Operating Cash Flow	-83,147,000
Investing Cash Flow	-81,234,000

Market Analysis
Market Cap	1,268,659,669
Price	26.06
BVPS	0.61
PB	19.21
EPS	-3.19
PS	5.41
FCF	-164,381,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view URGN documents filed with the SEC.

URGN Filings Clear

View A List of Tickers